Record #:

43846

Author(s):

Macmillan, Mike

Abstract:

"A Durham Biotech veteran gets another chance with $120 million from some notable backers." Tune Therapeutics, based in Durham and Seattle is developing transformative tools related to gene-based disease treatment. Matt Kane is CEO.

Source:

Business North Carolina (NoCar HF 5001 B8x), Vol. 43 Issue 8, August 2023, p12-13, por

Subject(s):

Biotechnology--Research; Biotechnology industries; Tune Therapeutics (Durham, NC); Biotechnology--Gene-based disease treatment